Is there an interrelationship between the effects of antipsychotics on psychopathology and on metabolism?

about

Is there an interrelationship between the effects of antipsychotics on psychopathology and on metabolism?

Item

http://www.wikidata.org/entity/Q50973671

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Is there an interrelationship ...... hopathology and on metabolism?

@en

Is there an interrelationship ...... hopathology and on metabolism?

@nl

type

Item

label

Is there an interrelationship ...... hopathology and on metabolism?

@en

Is there an interrelationship ...... hopathology and on metabolism?

@nl

prefLabel

Is there an interrelationship ...... hopathology and on metabolism?

@en

Is there an interrelationship ...... hopathology and on metabolism?

@nl

P1476

Is there an interrelationship ...... hopathology and on metabolism?

@en

P2093

Evgeny Chukhin

http://www.w3.org/2001/XMLSchema#string

Grigori Joffe

http://www.w3.org/2001/XMLSchema#string

Hanna Putkonen

http://www.w3.org/2001/XMLSchema#string

Jan-Henry Stenberg

http://www.w3.org/2001/XMLSchema#string

Markku Eronen

http://www.w3.org/2001/XMLSchema#string

Pirjo Takala

http://www.w3.org/2001/XMLSchema#string

Viacheslav Terevnikov

http://www.w3.org/2001/XMLSchema#string

P2860

The positive and negative syndrome scale (PANSS) for schizophrenia

H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs.

The 5-HT2C receptor and antipsychoticinduced weight gain - mechanisms and genetics.

Arterial stiffness and stroke in hypertension: therapeutic implications for stroke prevention.

Antipsychotic-induced metabolic and cardiovascular side effects in schizophrenia: a novel mechanistic hypothesis.

The association between weight change and symptom reduction in the CATIE schizophrenia trial.

Orlistat: current status in clinical therapeutics.

Metabolic and cardiovascular adverse effects associated with antipsychotic drugs.

Orlistat in clozapine- or olanzapine-treated patients with overweight or obesity: a 16-week open-label extension phase and both phases of a randomized controlled trial.

Effects of adjunctive treatment with aripiprazole on body weight and clinical efficacy in schizophrenia patients treated with clozapine: a randomized, double-blind, placebo-controlled trial.

P304

190-194

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/08039488.2015.1074283

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Helinä Hakko

Pirkko Räsänen

P577

2015-10-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26450657

http://www.w3.org/2001/XMLSchema#string